TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Unimedic Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
29,172
|
34,347
|
28,351 |
| Financial expenses |
599
|
342
|
191 |
| Earnings before taxes |
2,577
|
6,594
|
6,069 |
| EBITDA |
3,057
|
7,465
|
6,889 |
| Total assets |
17,167
|
17,972
|
17,864 |
| Current assets |
16,116
|
16,618
|
15,888 |
| Current liabilities |
3,167
|
5,182
|
7,640 |
| Equity capital |
8,182
|
6,821
|
3,313 |
| - share capital |
17
|
18
|
18 |
| Employees (average) |
31
|
27
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.7%
|
38.0%
|
18.5% |
| Turnover per employee |
941
|
1,272
|
1,050 |
| Profit as a percentage of turnover |
8.8%
|
19.2%
|
21.4% |
| Return on assets (ROA) |
18.5%
|
38.6%
|
35.0% |
| Current ratio |
508.9%
|
320.7%
|
208.0% |
| Return on equity (ROE) |
31.5%
|
96.7%
|
183.2% |
| Change turnover |
-4,007
|
5,913
|
6,043 |
| Change turnover % |
-12%
|
21%
|
27% |
| Chg. No. of employees |
4
|
0
|
2 |
| Chg. No. of employees % |
15%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.